-
Signature
-
/s/ David M. Roberts, by Raphael Avraham, as Attorney-in-Fact
-
Stock symbol
-
VRRM
-
Transactions as of
-
Aug 13, 2024
-
Transactions value $
-
-$1,772,827
-
Form type
-
4
-
Date filed
-
8/15/2024, 04:09 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
VRRM |
Class A Common Stock |
Options Exercise |
$650K |
+51.5K |
+7.65% |
$12.62 |
725K |
Aug 13, 2024 |
Direct |
F1 |
transaction |
VRRM |
Class A Common Stock |
Sale |
-$1.39M |
-51.5K |
-7.11% |
$27.01 |
673K |
Aug 13, 2024 |
Direct |
F1, F2 |
transaction |
VRRM |
Class A Common Stock |
Options Exercise |
$1.06M |
+77.5K |
+11.51% |
$13.69 |
751K |
Aug 13, 2024 |
Direct |
F1 |
transaction |
VRRM |
Class A Common Stock |
Sale |
-$2.09M |
-77.5K |
-10.32% |
$27.00 |
673K |
Aug 13, 2024 |
Direct |
F1 |
holding |
VRRM |
Class A Common Stock |
|
|
|
|
|
220K |
Aug 13, 2024 |
Trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
VRRM |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-51.5K |
-100% |
$0.00* |
0 |
Aug 13, 2024 |
Class A Common Stock |
51.5K |
$12.62 |
Direct |
F3 |
transaction |
VRRM |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-77.5K |
-66.67% |
$0.00 |
38.8K |
Aug 13, 2024 |
Class A Common Stock |
77.5K |
$13.69 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: